We are now recruiting for a Business Development Specialist for the R2B project First‑in‑Class PARP Inhibitors for Immuno‑Oncology to join our team at the Faculty of Biochemistry and Molecular Medicine (University of Oulu) on a fixed‑term part‑time or full‑time position (1 September 2026 – 31 August 2028). Total budget roughly 1 250 000 Eur.

About the role

The Business Development Specialist will work closely with the commercialization team and the Business Champion of the R2B project, helping to create and implement a commercialization strategy. Responsibilities include preparing required documentation and participating in early business‑development activities, such as fundraising for subsequent stages.

Responsibilities

• Create documentation required for commercialization in drug development.
• Participate in early business development activities for the R2B project, including fundraising for the next stages.

Bene...